marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
EyePoint Pharmaceuticals Financial Ratios 2011-2024 | EYPT
Annual Financial Ratios EyePoint Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-13.4 | -0.9 | -6.0 | -3.2 | -3.5 | -2.0 | -2.3 | -5.6 | 18.8 | -9.3 | -7.2 | -2.5 | -10.6 |
P/S |
20.6 | 2.2 | 9.5 | 4.2 | 9.6 | 35.3 | 5.6 | 74.6 | 4.5 | 35.8 | 40.0 | 17.3 | 18.4 |
EPS |
-1.8 | -2.7 | -2.0 | -3.5 | -5.4 | -1.3 | -0.5 | -0.7 | 0.2 | -0.5 | -0.5 | -1.2 | -0.4 |
EV (Enterprise Value) |
756 M | 81.3 M | 252 M | 172 M | 239 M | 119 M | 30.9 M | 116 M | 109 M | 117 M | 87.4 M | 63.5 M | 88.4 M |
EBITDA per Share |
-1.92 | -2.66 | -1.91 | -2.71 | -4.35 | -5.44 | -5.03 | -6.6 | 2.49 | -4.61 | -4.79 | -3.92 | -3.41 |
EV/EBITDA |
-4.5 | -4.2 | -4.9 | -3.3 | -1.4 | -5.1 | 13.7 | -8.6 | -7.1 | -6.9 | -11.8 | ||
PEG |
0.88 | 0.11 | 0.29 | -0.09 | 0.0 | 0.02 | -0.1 | 0.01 | 0.13 | -1.61 | -0.13 | 0.01 | 0.06 |
P/B |
3.6 | 1.0 | 1.9 | 7.8 | 23.5 | 8.9 | 3.2 | 5.8 | 5.1 | 8.3 | 11.1 | 4.5 | 2.4 |
P/CF |
505.6 | -1.4 | -7.0 | -9.7 | -3.4 | -4.7 | -2.1 | -7.4 | 11.8 | -11.4 | -9.7 | -6.5 | -27.7 |
ROE % |
-26.58 | -106.11 | -31.68 | -244.83 | -681.79 | -454.96 | -138.61 | -103.19 | 27.16 | -89.49 | -154.55 | -182.13 | -23.05 |
ROA % |
-19.93 | -56.70 | -22.18 | -49.49 | -77.83 | -74.19 | -98.97 | -68.15 | 19.61 | -58.91 | -73.24 | -120.58 | -18.31 |
ROCE % |
-28.19 | -103.39 | -29.98 | -48.54 | -77.88 | -52.54 | -138.76 | -82.09 | 22.13 | -66.04 | -92.93 | -59.60 | -23.77 |
Current Ratio |
4.0 | 2.1 | 3.3 | 4.2 | 3.6 | 1.8 | 3.4 | 5.9 | 8.9 | 9.1 | 3.8 | 5.0 | 5.0 |
DSO |
64.7 | 149.2 | 137.4 | 100.2 | 203.7 | 43.5 | 12.2 | 110.0 | 8.5 | 54.3 | 101.7 | 100.1 | 62.0 |
DIO |
- | - | - | 334.5 | 290.4 | - | - | - | - | - | - | - | - |
DPO |
- | - | - | 301.5 | 569.4 | - | - | - | - | - | - | - | - |
Operating Cycle |
64.7 | 149.2 | 137.4 | 434.7 | 494.2 | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
64.7 | 149.2 | 137.4 | 133.2 | -75.3 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios EyePoint Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.54 | -0.58 | - | -0.33 | -0.61 | -0.56 | - | -0.49 | -0.52 | -0.56 | - | -0.58 | -0.35 | -0.5 | - | -0.3 | -1.04 | -1.14 | -0.1 | -0.15 | -0.11 | -0.2 | -0.12 | -0.44 | -0.62 | -0.44 | -0.13 | -0.15 | -0.13 | -0.15 | - | -0.21 | - | -0.15 | -0.18 | -0.17 | -0.34 | -0.17 | -0.14 | 0.7 | -0.14 | 0.7 | -0.13 | -0.14 | -0.13 | -0.14 | -0.11 | -0.11 | -0.11 | -0.11 | -0.84 | -0.12 | -0.84 | -0.12 |
EBITDA per Share |
- | - | - | - | - | -0.57 | - | -0.48 | -0.51 | -0.49 | - | -0.52 | -0.36 | -0.44 | - | -0.14 | -0.89 | -0.99 | -0.08 | -0.13 | -0.09 | -0.15 | -0.12 | -0.18 | -0.18 | -0.18 | -0.13 | -0.15 | -0.13 | -0.15 | - | -0.21 | - | -0.21 | -0.17 | -0.17 | -0.18 | -0.17 | -0.13 | 0.71 | -0.14 | 0.71 | -0.12 | -0.14 | -0.13 | -0.14 | -0.11 | -0.11 | -0.11 | -0.11 | -0.81 | -0.12 | -0.85 | -0.12 |
ROE % |
-69.95 | -96.56 | -88.54 | -102.05 | -94.04 | -66.84 | -38.90 | -56.90 | -61.40 | -57.94 | -37.98 | -58.48 | -60.98 | -121.46 | -161.40 | -286.37 | -453.71 | -521.89 | -681.79 | -587.63 | -487.81 | -441.26 | -298.34 | -325.91 | -304.35 | -271.24 | -249.69 | -191.77 | -175.29 | -117.37 | -100.47 | -135.97 | -112.19 | -147.69 | -124.32 | -100.99 | -17.34 | 5.98 | 170.00 | 154.73 | 71.39 | 38.38 | -147.31 | -138.30 | -128.19 | -101.68 | -72.50 | -151.75 | -142.85 | -170.37 | -158.14 | -6.89 | -46.64 | -6.48 |
ROA % |
-35.02 | -38.32 | -34.62 | -42.97 | -43.45 | -38.98 | -25.51 | -35.43 | -28.42 | -34.02 | -22.08 | -26.23 | -20.45 | -28.97 | -32.63 | -46.89 | -64.19 | -65.83 | -77.83 | -78.40 | -99.33 | -127.62 | -143.63 | -169.53 | -172.04 | -158.96 | -148.61 | -108.23 | -92.06 | -61.31 | -51.93 | -73.24 | -62.48 | -78.29 | -70.88 | -59.37 | 5.61 | 3.66 | 109.62 | 102.88 | 39.64 | 35.99 | -77.41 | -72.93 | -67.64 | -58.68 | -48.37 | -105.96 | -100.66 | -125.06 | -117.82 | -5.63 | -37.06 | -5.15 |
ROCE % |
-79.23 | -104.00 | -91.81 | -105.30 | -94.23 | -67.18 | -37.15 | -53.66 | -56.68 | -54.25 | -36.23 | -46.79 | -40.83 | -90.71 | -132.43 | -240.29 | -398.52 | -460.40 | -574.56 | -495.94 | -363.17 | -267.13 | -127.27 | -156.66 | -187.37 | -220.02 | -250.73 | -192.73 | -176.16 | -118.16 | -101.17 | -136.85 | -113.17 | -148.84 | -125.59 | -102.02 | -17.48 | 6.08 | 171.86 | 156.51 | 72.33 | 39.09 | -148.49 | -139.56 | -129.47 | -102.90 | -73.61 | -153.59 | -144.75 | -172.47 | -160.23 | -7.18 | -47.13 | -6.76 |
Current Ratio |
3.7 | 3.4 | 4.0 | 1.6 | 1.5 | 2.0 | 2.1 | 2.6 | - | 3.1 | 3.3 | 2.2 | 2.5 | 2.6 | 1.2 | 1.2 | 1.2 | 1.2 | 1.1 | 1.1 | 1.1 | 1.1 | 1.9 | 1.9 | 1.9 | 1.9 | 3.3 | 3.1 | 3.5 | 3.5 | 4.0 | 2.4 | 2.9 | 2.9 | 2.5 | 3.2 | 3.6 | 3.6 | 5.1 | 5.5 | 2.9 | 2.9 | 2.5 | 2.7 | 1.9 | 1.9 | 2.9 | 3.2 | 3.0 | 3.0 | 3.5 | 5.5 | 4.9 | 4.9 |
DSO |
7.6 | 10.5 | - | 34.3 | 107.1 | 153.9 | - | 95.1 | 77.3 | 186.3 | - | 144.6 | 138.9 | 135.7 | - | 55.0 | 209.3 | 126.8 | 120.1 | 413.4 | 143.9 | 272.0 | 23.4 | 117.7 | 80.0 | 45.0 | 28.1 | 63.8 | 17.4 | 54.8 | 7.0 | 156.5 | 7.5 | 174.8 | 99.1 | 116.6 | 107.9 | 132.1 | 2293.4 | 46.8 | 90.5 | 2.1 | 134.7 | 130.6 | 92.0 | 118.1 | 147.1 | 157.2 | 150.8 | 163.6 | 125.9 | 43.1 | 122.1 | - |
DIO |
401.6 | 246.8 | - | 335.5 | 212.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 276.3 | 334.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
1341.4 | 677.4 | - | 770.4 | 513.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 541.8 | 944.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
409.2 | 257.3 | - | 369.8 | 319.2 | 153.9 | - | 95.1 | 77.3 | 186.3 | - | 144.6 | 138.9 | 135.7 | - | 55.0 | 209.3 | 126.8 | 120.1 | 413.4 | 420.2 | 606.2 | 23.4 | 117.7 | 80.0 | 45.0 | 28.1 | 63.8 | 17.4 | 54.8 | 7.0 | 156.5 | 7.5 | 174.8 | 99.1 | 116.6 | 107.9 | 132.1 | 2293.4 | 46.8 | 90.5 | 2.1 | 134.7 | 130.6 | 92.0 | 118.1 | 147.1 | 157.2 | 150.8 | 163.6 | 125.9 | 43.1 | 122.1 | - |
Cash Conversion Cycle |
-932.2 | -420.1 | - | -400.6 | -194.3 | 153.9 | - | 95.1 | 77.3 | 186.3 | - | 144.6 | 138.9 | 135.7 | - | 55.0 | 209.3 | 126.8 | 120.1 | 413.4 | -121.6 | -338.4 | 23.4 | 117.7 | 80.0 | 45.0 | 28.1 | 63.8 | 17.4 | 54.8 | 7.0 | 156.5 | 7.5 | 174.8 | 99.1 | 116.6 | 107.9 | 132.1 | 2293.4 | 46.8 | 90.5 | 2.1 | 134.7 | 130.6 | 92.0 | 118.1 | 147.1 | 157.2 | 150.8 | 163.6 | 125.9 | 43.1 | 122.1 | - |
All numbers in USD currency